• SCH772984 HCl: ERK1/2 Inhibition Workflows

  2026-09-07

  SCH772984 HCl provides a nanomolar tool for separating ERK1/2-dependent signaling from downstream effects on proliferation, resistance, and telomerase biology. This practical guide connects validated MAPK experiments with a carefully bounded, hypothesis-generating workflow inspired by APEX2–TERT research in human embryonic stem cells and melanoma.

• Bergenin Targets γδT17 Cells in Psoriasis

  2026-09-07

  The reference study identifies a previously unrecognized PPARγ–PROX1 pathway through which bergenin suppresses pathogenic γδT17-cell activity in psoriasis. Its combination of animal modeling, metabolic analysis, ubiquitination assays, and chromatin studies links PROX1 degradation to reduced fatty acid oxidation and IL-17A transcription, offering a mechanistic framework for cell-selective anti-inflammatory research.

• KLF4 Control of AgRP Isoforms in Mouse Metabolism

  2026-09-05

  This study identifies KLF4 as a transcriptional regulator of Agrp in mouse hypothalamic AgRP neurons and distinguishes the contributions of three Agrp isoforms across tissues. Its conditional-genetic, dietary, and cell-based experiments show that KLF4 promotes Agrp expression under lean conditions, whereas prolonged high-fat feeding can override this regulatory relationship.

• Purmorphamine: Smoothened Agonist Workflows

  2026-09-05

  Purmorphamine is a tunable Smoothened agonist for connecting Hedgehog pathway activation with osteogenic, neural, and sensory readouts. This guide converts product specifications and honeybee Smo findings into practical dosing, assay, and troubleshooting strategies.

• Streptavidin-FITC for LNP Biotin Detection

  2026-09-04

  Streptavidin-FITC converts biotinylated LNP, nucleic-acid, and antibody workflows into bright, microscope- and flow-compatible readouts. This guide focuses on distinguishing particle association from functional delivery while providing practical controls for charge-, corona-, and endolysosomal studies.

• Dacarbazine Workflows for Cancer Research

  2026-09-04

  Build more reproducible Dacarbazine cytotoxicity studies with solvent-aware preparation, time-resolved readouts, and orthogonal validation. This guide connects practical assay execution with translational questions in melanoma, Hodgkin lymphoma, and sarcoma research while clarifying what supportive-care evidence can—and cannot—show.

• Anlotinib hydrochloride Assay Workflows

  2026-09-03

  Build reproducible angiogenesis assays around receptor phosphorylation, endothelial phenotypes, and ERK pathway readouts. This guide translates a clinically informative desmoplastic small round cell tumor case into practical cancer research workflows while separating literature evidence from optimization recommendations.

• In Vitro Drug Response Metrics in Cancer Research

  2026-09-02

  Hannah Schwartz’s dissertation distinguishes relative viability from fractional viability, showing that growth inhibition and cell killing are related but non-equivalent dimensions of anticancer drug response. This measurement framework helps researchers design better time-resolved experiments, interpret apoptosis assay data more carefully, and avoid treating reduced viability as definitive evidence of cell death.

• Streptavidin-FITC for Biotin Tracking Workflows

  2026-09-02

  Streptavidin-FITC converts biotinylated antibodies, nucleic acids, and nanoparticles into measurable FITC fluorescence across imaging and flow assays. Its strongest use-case is modular tracking, where the same high-affinity reagent can connect intracellular trafficking studies with immunohistochemistry, immunofluorescence, and flow cytometry.

• AGO1 Controls Protein Folding in Stem Cell Fate

  2026-09-02

  The 2024 Developmental Cell study shows that AGO1 and AGO2 have opposing roles in mouse embryonic stem cell fate: AGO1 sustains stemness, whereas AGO2 promotes differentiation through the miRNA pathway. Its central innovation is the identification of an RNA-independent AGO1–HOP interaction that supports folding of transcriptional regulators with intrinsically disordered regions.

• Berberine Hydrochloride: From AMPK to Mitochondria

  2026-09-01

  Berberine hydrochloride connects AMPK-driven metabolic regulation with lipid, apoptotic, ferroptotic, and mitochondrial readouts. This guide shows how to build a mechanistically disciplined workflow for metabolic disease research and cardiovascular disease research.

• WEHI-539: Selective BCL-XL Inhibitor Workflows

  2026-08-31

  WEHI-539 enables selective interrogation of BCL-XL-dependent survival, from mitochondrial apoptosis assays to cancer stem cell sensitization. This workflow-focused guide separates biochemical potency from cellular response and shows how to troubleshoot formulation, timing, controls, and combination experiments.

• PD0325901 for Reliable Cell Assays

  2026-08-31

  This scenario-based guide explains how PD0325901 (SKU A3013) can support mechanistic cell viability, proliferation, and cytotoxicity experiments through MEK pathway inhibition. It combines formulation guidance, assay controls, data interpretation, and evidence-linked recommendations for more defensible laboratory decisions.

• MnTBAP Chloride: A Redox Assay Strategy

  2026-08-30

  MnTBAP Chloride is a cell-permeable SOD mimetic for testing how mitochondrial superoxide connects oxidative stress with inflammation and behavior. This article develops an assay-centered framework that extends chronic-stress findings into practical study design, controls, and interpretation.

• ATP as a Translational Map of Mitochondrial Control

  2026-08-29

  Adenosine Triphosphate is more than a readout of cellular energy. This thought-leadership article connects ATP state, OGDH regulation, mitochondrial proteostasis, and purinergic receptor signaling to help translational researchers design experiments that distinguish correlation from mechanism.

8654 records 1/577 page Next 12345 下5页 Last page